Skip to main content

MRI-guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniques.

Imschweiler T, Haueisen H, Kampmann G, Rageth L, Seifert B, Rageth C, Freiwald B, Kubik-Huch RA

Publication: Eur Radiol (2014) • Vol 24 • Page 128-35PMID: 23979106View on PubMed

Purpose

This paper retrospectively compared technical success, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of breast vacuum-assisted biopsies (VAB) obtained under magnetic-resonance imaging (MRI) guidance with those obtained under ultrasound (US)- and stereotactic-guidance.

Conclusion

The technical success rate was slightly higher for US-guided than MRI-guided biopsies. Overall sensitivity and NPV were higher for US-guided VAB than stereotactically-guided VAB and MRI-guided VAB. However, specificity and PPV were higher for MRI-guided VAB than US-guided VAB and stereotactically-guided VAB.

 

Studies (1)

Purpose

This study retrospectively compared technical success, sensitivity, specificity, PPV, and NPV of breast VAB obtained under MRI-guidance with those obtained under US- and stereotactic-guidance.  A total of 9,113 11-gauge or greater VAB were obtained at 53 minimally invasive breast biopsy (MIBB) centers. Guidance was by MRI in 557 cases (6%), stereotactic device in 5391 cases (59%) or by US in 2596 cases (28%). MRI guidance was used more frequently in patients with a previous history of breast carcinoma than stereotactic or US-guidance (P<0.001, both) and in patients with a family history of breast cancer (P<0.001). All biopsies consisted of at least 12 samples.

Summary of Findings

Technical success (defined as specimen being suitable for histology) occurred in a slightly higher percentage of US-guided than MRI-guided biopsies (99.6% versus 98.4%, P<0.001). The false negative rate for malignancy was 3% for MRI-guided biopsies but only 1% and 0.4% for stereotactically- and US-guided biopsies, respectively. MRI-guided biopsies were more likely to be diagnostically upgraded from benign or high-risk to malignant after excision than US-guided or stereotactic biopsies (P<0.001, both).  Surgical excisions did not confirm the malignancy identified in the biopsy in 3% of malignant MRI-guided biopsies, 7% of malignant stereotactically-guided biopsies, and 4% of malignant US-guided biopsies. Overall sensitivity and NPV were slightly higher for US-guided VAB (95.7% and 91.7%, respectively) than stereotactically-guided VAB (91.5%, and 80.5%, respectively) and significantly higher than MRI-guided VAB (79.7% and 62.7%, respectively). However, the specificity and PPV were higher for MRI-guided biopsies (92.2% and 96.5%, respectively) than US-guided biopsy (91.7% and 95.7%, respectively) and stereotactically-guided biopsies (81.9% and 92.2%, respectively). 

  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
    NeoplasticBenign
  • Platforms

    MorphologyLight microscopy
    MorphologyH-and-E microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionMethod of tissue acquisition
    Magnetic resonance imaging-guided biopsy
    Sterotactic-guided biopsy
    Ultrasound-guided biopsy